Showing 101-105 of 138 clinical outcomes management & analytics:
OM1 Rheumatoid Arthritis Registry Reaches More Than 200,000 Patients Prospectively Followed With Deep Clinical Data

BOSTON, April 20, 2021 /PRNewswire/ — OM1, a leading real-world data, outcomes and technology company with a focus on chronic diseases, announced its Rheumatoid Arthritis (RA) registry now includes longitudinal clinical data from rheumatology specialists on more than 200,000 patients. OM1 also offers other specialty rheumatology registries, including Juvenile Idiopathic Arthritis (JIA), which has deep[…]

Bridging Clinical Research with Clinical Practice: Use of AI in Predicting Outcomes

Wed, May 18, 2021 11:00 AM – 12:00 PM EDT Register Artificial Intelligence (AI) is increasingly being applied to improve medical research and clinical practice. Join this panelist discussion exploring AI applications and high-performance predictive modeling for: – Improving research efficiency – Accelerating personalized treatment development – Supporting clinical decision making Presenters: – Prakash Jayakumar,[…]

Real-World Data and External Control Arms 101

Thu, Apr 29, 2021 11:30 AM – 12:30 PM EDT Register Real-world data is increasingly being used to develop external control arms for trial planning and regulatory submissions. Understanding the basics of what they are and how they can be used effectively are critical to success. Join Dr. Richard Gliklich, CEO of OM1, as he[…]

American Academy Of Dermatology Collaborates With OM1 To Empower More Measured & Precise Care And Treatments For Dermatology

BOSTON, April 8, 2021 /PRNewswire/ — OM1, a real-world outcomes and technology company, today announced a strategic collaboration with the American Academy of Dermatology (AAD) connecting the Academy’s DataDerm™ clinical data registry to OM1’s real-world data and evidence platforms. The AAD estimates that 1 in 4 Americans (more than 85 million) see a physician for[…]

Black Women Less Likely To Undergo Digital Breast Tomosynthesis

M.D. Alert Published: March 5, 2021 Read the Full Commentary >> (Reuters Health) – Women have better screening outcomes with digital breast tomosynthesis, but a new study suggests that Black women have less access to this imaging modality. Researchers examined data on 385,503 women screened at one of 63 U.S. breast imaging facilities between 2015[…]

1 … 19 20 21 22 23 … 28